Preparation of 2'-fluoro-2'-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
US-2016024061-A1 · Jan 28, 2016 · US
US10577359B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10577359-B2 |
| Application number | US-201715425198-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 6, 2017 |
| Priority date | Sep 14, 2004 |
| Publication date | Mar 3, 2020 |
| Grant date | Mar 3, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides (i) processes for preparing a 2′-deoxy-2′-fluoro-2′-methyl-D-ribonolactone derivatives, (ii) conversion of intermediate lactones to nucleosides with potent anti-HCV activity, and their analogues, and (iii) methods to prepare the anti-HCV nucleosides containing the 2′-deoxy-2′-fluoro-2′-C-methyl-ß-D-ribofuranosyl nucleosides from a preformed, preferably naturally-occurring, nucleoside.
Opening claim text (preview).
The invention claimed is: 1. A compound of formula 51B: wherein: each R 1 is independently (C 1 -C 6 ) alkyl, phenyl or benzyl; or two R 1 with the carbon attached thereto form a cyclopentyl or cyclohexanyl group; R 2 is hydrogen, (C 1 -C 6 ) alkyl, hydroxymethyl, methoxymethyl, halomethyl, vinyl, halovinyl, ethynyl, haloethynyl, allyl or haloallyl; R 3 is (C 1 -C 6 ) alkyl, hydroxymethyl, methoxymethyl, halomethyl, vinyl, halovinyl, ethynyl, haloethynyl, allyl or haloallyl; R 4 is hydrogen, aryl, arylalkyl or (C 1 -C 6 ) alkyl; Nu is F, Cl, Br, N 3 , CN, NO 3 , CF 3 , SCN, OR or NR 2 where each R is independently arylalkyl or (C 1 -C 6 ) alkyl; and M + is tetrabutylammonium, tetraethylammonium, tetramethylammonium, sodium, potassium, cesium, rubidium or silver. 2. A compound of formula 52B: wherein: each R 1 is independently (C 1 -C 6 ) alkyl, phenyl or benzyl; or two R 1 with the carbon attached thereto form a cyclopentyl or cyclohexanyl group; R 2 is hydrogen, (C 1 -C 6 ) alkyl, hydroxymethyl, methoxymethyl, halomethyl, vinyl, halovinyl, ethynyl, haloethnyl, allyl or haloallyl; R 3 is (C 1 -C 6 ) alkyl, hydroxymethyl, methoxymethyl, halomethyl, vinyl, halovinyl, ethynyl, haloethynyl, allyl or haloallyl; R 4 is hydrogen, aryl, arylalkyl or (C 1 -C 6 ) alkyl; and Nu is F, Cl, Br, N 3 , CN, NO 3 , CF 3 , SCN, OR or NR 2 where each R is independently arylalkyl or (C 1 -C 6 ) alkyl.
for RNA viruses · CPC title
Oxygen atoms · CPC title
Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems · CPC title
Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title
in position 2, the oxygen atom being in its keto or unsubstituted enol form · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.